MRSN logo

Mersana Therapeutics (MRSN) Current Liabilities

Annual Current Liabilities

$63.64 M
-$27.90 M-30.48%

31 December 2023

MRSN Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$68.30 M
+$6.12 M+9.84%

30 September 2024

MRSN Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRSN Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-30.5%+0.5%
3 y3 years+112.1%+55.1%
5 y5 years-8.3%+205.1%

MRSN Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-30.5%+112.1%-25.4%+55.1%
5 y5 years-30.5%+164.4%-25.4%+290.5%
alltimeall time-30.5%+492.8%-25.4%+290.5%

Mersana Therapeutics Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$68.30 M(+9.8%)
June 2024
-
$62.18 M(+16.4%)
Mar 2024
-
$53.41 M(-16.1%)
Dec 2023
$63.64 M(-30.5%)
$63.64 M(-6.3%)
Sept 2023
-
$67.93 M(-9.3%)
June 2023
-
$74.92 M(-10.2%)
Mar 2023
-
$83.40 M(-8.9%)
Dec 2022
$91.53 M(+92.6%)
$91.53 M(+3.1%)
Sept 2022
-
$88.79 M(+24.2%)
June 2022
-
$71.47 M(+26.6%)
Mar 2022
-
$56.46 M(+18.8%)
Dec 2021
$47.52 M(+58.4%)
$47.52 M(+8.0%)
Sept 2021
-
$44.02 M(+8.8%)
June 2021
-
$40.47 M(+15.9%)
Mar 2021
-
$34.92 M(+16.4%)
Dec 2020
$30.00 M
$30.00 M(+42.4%)
DateAnnualQuarterly
Sept 2020
-
$21.07 M(-6.0%)
June 2020
-
$22.42 M(+28.2%)
Mar 2020
-
$17.49 M(-27.3%)
Dec 2019
$24.07 M(-65.3%)
$24.07 M(+7.5%)
Sept 2019
-
$22.38 M(-6.4%)
June 2019
-
$23.92 M(+5.9%)
Mar 2019
-
$22.59 M(-67.5%)
Dec 2018
$69.42 M(+117.8%)
$69.42 M(+120.8%)
Sept 2018
-
$31.44 M(-1.4%)
June 2018
-
$31.88 M(+8.7%)
Mar 2018
-
$29.34 M(-8.0%)
Dec 2017
$31.88 M(+12.3%)
$31.88 M(+30.1%)
Sept 2017
-
$24.51 M(-22.0%)
June 2017
-
$31.43 M(-4.5%)
Mar 2017
-
$32.90 M(+15.9%)
Dec 2016
$28.39 M(+164.4%)
$28.39 M
Dec 2015
$10.73 M
-

FAQ

  • What is Mersana Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Mersana Therapeutics?
  • What is Mersana Therapeutics annual current liabilities year-on-year change?
  • What is Mersana Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Mersana Therapeutics?
  • What is Mersana Therapeutics quarterly current liabilities year-on-year change?

What is Mersana Therapeutics annual total current liabilities?

The current annual current liabilities of MRSN is $63.64 M

What is the all time high annual current liabilities for Mersana Therapeutics?

Mersana Therapeutics all-time high annual total current liabilities is $91.53 M

What is Mersana Therapeutics annual current liabilities year-on-year change?

Over the past year, MRSN annual total current liabilities has changed by -$27.90 M (-30.48%)

What is Mersana Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of MRSN is $68.30 M

What is the all time high quarterly current liabilities for Mersana Therapeutics?

Mersana Therapeutics all-time high quarterly total current liabilities is $91.53 M

What is Mersana Therapeutics quarterly current liabilities year-on-year change?

Over the past year, MRSN quarterly total current liabilities has changed by +$368.00 K (+0.54%)